Delays and debacles: Securing urgent interlocutory orders for misuse of confidential information in recent court decisions
Tara Koh, Associate and Leanne Oitmaa, Principal discuss the misuse of confidential information and the difficulties that are likely to be encountered when seeking urgent relief.
Read more
Griffith Hack authors IP Protection for Pharmaceuticals (Australia) for Thomson Reuters’ Practical Law
Griffith Hack’s Gavin Adkins and Dr Tim Fyfe have authored a Practice Note for Thomson Reuters’ Practical Law.
Read more
Twenty one Griffith Hack principals recognised as WIPR Leaders for 2024
Twenty one Griffith Hack principals have been individually recognised in this years’ World Intellectual Property Review Leaders Guide.
Read more
What’s going on with Australia’s proposed patent notification scheme for generic and biosimilar medicines?
The proposed patent notification scheme for generic and biosimilar medicines by the Australian Therapeutic Goods Administration (TGA) seems to have fallen of its priority list. Gavin Adkins, from our Law and Trade Marks team, reflects on the TGA’s consultation process, its subsequent announcements and the impact on innovators and generics.
Read more
Griffith Hack Law and Trade Marks team continue to shine in WTR 1000 for 2024
Our firm continues its top Gold ranking for trade mark prosecution and strategy and Bronze for enforcement and litigation in the WTR 1000 for 2024.
Read more
Recognition for Griffith Hack and Derek Baigent in The Legal 500 guide 2024
Griffith Hack principal Derek Baigent has been recognised as one of Australia’s leaders in intellectual property in The Legal 500 Australia guide for 2024.
Read more
Griffith Hack to attend the APAA 20th General Assembly in Singapore
Greg Munt, Gavin Adkins, Jessica Lee, Dr Simone Shu-Yen Lee and Dr Jenny Park will represent Griffith Hack at the 20th General Assembly of the Asian Patent Attorneys Association in Singapore.
Read more
Australian Government again denied $325m damages claim in clopidogrel injunction dispute
The Full Court of the Federal Court of Australia has dismissed the Commonwealth’s appeal against a 2020 decision to deny it $325m in damages in a dispute relating to the antiplatelet drug clopidogrel.
Read more
Griffith Hack authors Patents 2023 in Lexology’s Getting the Deal Through
Amanda Stark and Gavin Adkins have authored the Australian and New Zealand chapters of Patents 2023 in Lexology’s Getting the Deal Through.
Read more
Full Court correct in deciding that only humans can invent
High Court confirms that an artificial intelligence system can not be named as an inventor of a patent.
Read more
New unfair contract term laws in Australia introduce large financial penalties
Significant changes to the unfair contract term provisions in the Australian Consumer Law, including potential financial penalties, will soon apply.
Read more
Don’t lose your IP rights through company deregistration
Gavin Adkins and Emma Mitchell explain why it is so important to transfer the ownership of a company’s IP rights before deregistration.
Read more
Major changes to unfair contract term laws in Australia are still in play
Draft legislation to strengthen the existing unfair contract term protections in the Australian Consumer Law was recently released.
Read more
Kellie Stonier, Gavin Adkins recognised in Doyle’s Guide 2022
Griffith Hack has been recognised by Doyle’s Guide 2022 across multiple categories, with principals Kellie Stonier and Gavin Adkins receiving individual accolades.
Read more
Reversal of fortune – Full Court decides that an artificial intelligence is not an “inventor”
Anthony Selleck reviews the decision in Commissioner of Patents v Thaler [2022] FCAFC 62 which reverses an earlier ruling that artificial intelligence can be an “inventor” for the purposes of the Australian Patents Act 1990.
Read more
Changes to how influencers can promote therapeutic goods in Australia
The Therapeutic Goods Administration has set out new guidelines that govern how influencers can promote products on social media in return for payment or free products or services from brands.
Read more
The mother of all trade mark fights: Energy Beverages knocked out of the coffee arena
A series of trade marks disputes over coffee products provides important learnings for businesses looking to register trade marks for consumer goods and services.
Read more
Awkward first dates:
How is patent term extension calculated when a patent covers more than one pharmaceutical substance with regulatory approval?
Bayer Pharma Aktiengesellschaft [2022] APO
Read more
Your Australian patent application has been opposed – what next?
Australia’s pre‑grant opposition proceedings are playing a more significant role in the strategies of patentees and challengers. So what should a patent owner do when faced with an opposition in Australia?
Read more
Innovation patents: options for challenging problematic cases
What are your options if you identify an innovation patent that affects your freedom to operate?
Read more
Expert evidence keeps RAFT buoyant in strawman patent opposition
Commonwealth Scientific and Industrial Research Organisation (CSIRO) v Cytec Industries Inc. [2021] APO 27
Read more
Guidance on patenting diagnostics in Australia: Ariosa Diagnostics v Sequenom
Federal Court confirms that a non-invasive diagnostic test for prenatal conditions is patentable subject matter in Australia.
Read more
UPDATE: Confidentiality notices at the end of emails are not (completely) pointless
Nearly three years ago, we reported on a decision of the Australian Designs Office that suggested that the automatically generated ‘Confidentiality Notice’ in the footer to your email may not always be effective.
Read more
The rise of trade secret protections internationally and what it might mean for Australia
There have been several significant developments internationally in trade secret protections in recent years that have arguably increased the risks of misappropriation of trade secrets.
Read more
Wine export label directory a win for Australian wine brand owners
A new wine export label directory to help Australian wine producers protect their intellectual property rights is expected to commence in April 2021.
Read more
Sanofi avoid $325M damages claim by Australia’s Commonwealth Government
In a significant decision for the pharmaceutical industry, Justice Nicholas dismissed the Commonwealth of Australia’s compensation claim from Sanofi.
Read more
Griffith Hack announces the elevation of two team members to principal
Griffith Hack is thrilled to formally announce the elevation of Gavin Adkins and Robyn Heard to principal.
Read more
Griffith Hack ranked in Legal 500 Asia Pacific 2020 Guide
The recently released Legal 500 Asia Pacific Guide for 2020 reconfirms Griffith Hack’s position as Australia’s highest ranked specialist IP firm.
Read more
Dior and the protection of Indigenous Knowledge in Australia’s IP system
We discuss some of the issues surrounding interactions between Indigenous Knowledge and Intellectual Property systems.
Read more